UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000049145 |
|---|---|
| Receipt number | R000055980 |
| Scientific Title | Effectiveness of Guideline for Dissemination and Education in Psychiatric Treatment |
| Date of disclosure of the study information | 2022/10/06 |
| Last modified on | 2022/10/06 23:20:14 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effectiveness of Guideline for Dissemination and Education in Psychiatric Treatment
Acronym
EGUIDE study
Scientific Title
Effectiveness of Guideline for Dissemination and Education in Psychiatric Treatment
Scientific Title:Acronym
EGUIDE study
Region
| Japan |
Condition
Condition
psychiatrists treating patients with schizophrenia and depression
Classification by specialty
| Psychiatry |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To conduct nationwide educational lectures based on guidelines for psychiatric care and to examine the effect of the guidelines.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Scale for comprehension of guidelines schizophrenia and depression
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Educational,Counseling,Training
Type of intervention
| Other |
Interventions/Control_1
Educational lectures of Japanese treatment guidelines for schizophrenia and depression
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Psychiatrists treating patients with schizophrenia and depression
Key exclusion criteria
non-psychiatrist
Target sample size
10
Research contact person
Name of lead principal investigator
| 1st name | Atsushi |
| Middle name | |
| Last name | Furuichi |
Organization
Toyama University Hospital
Division name
Department of Neuropsychiatry
Zip code
930-0194
Address
2630 sugitani, Toyama, 930-0194, Japan
TEL
0764342281
ichi1031@med.u-toyama.ac.jp
Public contact
Name of contact person
| 1st name | Atsushi |
| Middle name | |
| Last name | Furuichi |
Organization
Toyama University Hospital
Division name
Department of Neuropsychiatry
Zip code
930-0194
Address
2630 sugitani, Toyama, 930-0194, Japan
TEL
0764342281
Homepage URL
ichi1031@med.u-toyama.ac.jp
Sponsor or person
Institute
National Institute of Mental Health, National Center of Neurology and Psychiatry
Institute
Department
Personal name
Funding Source
Organization
Japan Agency for Medical Research and Development
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Center for Clinical Research, Toyama University Hospital
Address
2630 sugitani, Toyama, 930-0194, Japan
Tel
0764342281
rinri@adm.u-toyama.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2022 | Year | 10 | Month | 06 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2023 | Year | 08 | Month | 10 | Day |
Date of IRB
Anticipated trial start date
| 2023 | Year | 10 | Month | 20 | Day |
Last follow-up date
| 2027 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2022 | Year | 10 | Month | 06 | Day |
Last modified on
| 2022 | Year | 10 | Month | 06 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055980
